Proton pump inhibitors and colorectal cancer: A systematic review

Proton pump inhibitor use and the efficacy of chemotherapy in metastatic colorectal cancer: a post hoc analysis of a randomized phase 3 trial ( AXEPT )

(2021) Sun Young Kim et al.   ONCOLOGIST

Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy

(2021) Ganessan Kichenadasse et al.   Journal of the National Comprehensive Cancer Network

Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population

(2020) Jeffrey K. Lee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis

(2020) Hyun Jin Song et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Colorectal cancer occurrence and treatment based on changes in intestinal flora

(2020) Huifang Si et al.   SEMINARS IN CANCER BIOLOGY

Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study

(2020) Wei-Yi Lei et al.   Clinics and Research in Hepatology and Gastroenterology

Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies

(2020) Ana Babic et al.   BRITISH JOURNAL OF CANCER

Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies

(2020) Tianyi Ma et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil

(2019) Masae Sekido et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Use of proton pump inhibitors and the risk of hepatocellular carcinoma

(2019) Tien-En Chang et al.   Journal of the Chinese Medical Association

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

(2019) Sunny H. Wong et al.   Nature Reviews Gastroenterology & Hepatology

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Use of proton pump inhibitors in adults in France: a nationwide drug utilization study

(2019) Marion Lassalle et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study

(2019) Onuma Sattayalertyanyong et al.   International Journal of Clinical Pharmacy

Proton pump inhibitor use and cancer mortality

(2018) Siri A. Tvingsholm et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer

(2018) Grace G. Wong et al.   Clinical Colorectal Cancer

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics

(2018) Katharine J. Herbert et al.   Cell Death & Disease

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

(2017) Vincenzo Savarino et al.   European Journal of Internal Medicine

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer

(2017) Jin-Liang Zhang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase

(2017) Mengzhu Zheng et al.   Oncotarget

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer

(2017) Xiaoyu Wang et al.   Oncotarget

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

(2017) Michael P. Chu et al.   JAMA Oncology

Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study

(2017) In Cheol Hwang et al.   PLoS One

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

(2016) Julia Sun et al.   Clinical Colorectal Cancer

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis

(2016) An Tran-Duy et al.   Clinical Gastroenterology and Hepatology

A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival

(2016) C. Graham et al.   Current Oncology

Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase

(2016) Xiaoyu Zeng et al.   Oncotarget

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Paradoxically Augmented Anti-Tumorigenic Action of Proton Pump Inhibitor and Gastrin in APCMin/+ Intestinal Polyposis Model1

(2015) Young-Min Han et al.   NEOPLASIA

Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (Anticancer effects of 3-bromopyruvate through antagonizing Warburg effect)

(2013) Salah Mohamed El Sayed et al.   MEDICAL HYPOTHESES

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

(2013) Jai Moo Shin et al.   Journal of Neurogastroenterology and Motility

Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?

(2012) N R Budha et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats

(2011) Chinthalapally Rao   INTERNATIONAL JOURNAL OF ONCOLOGY

Novel Application of Proton Pump Inhibitor for the Prevention of Colitis-Induced Colorectal Carcinogenesis beyond Acid Suppression

(2010) Y. J. Kim et al.   Cancer Prevention Research

Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy

(2010) Enrico P Spugnini et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Colorectal cancer risk in relation to use of acid suppressive medications

(2009) Jessica Chubak et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2008) Eva M. van Soest et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY